The biology of allogeneic hematopoietic cell resistance
- PMID: 19913629
- PMCID: PMC4910691
- DOI: 10.1016/j.bbmt.2009.11.005
The biology of allogeneic hematopoietic cell resistance
Abstract
At the most basic level, success of an allogeneic hematopoietic cell transplantation (HCT) procedure relies upon the engraftment of recipients with donor hematopoietic stem cells (HSCs) that will generate blood formation for the life of that individual. The formula to achieve durable HSC engraftment involves multiple factors including the recipient conditioning regimen, the nature of the genetic disparity between donor and recipient, and the content of the hematopoietic graft. Animal and clinical studies have shown that the biology of host resistance is complex, involving both immune and nonimmune elements. In this article, we review the factors that contribute to host resistance, describe emerging concepts on the basic biology of resistance, and discuss hematopoietic resistance as it relates specifically to patients with severe combined immunodeficiencies (SCID)- disorders that bring unique insights into the dynamics of cell replacement by allogeneic HSCs and progenitor cells.
Copyright 2010. Published by Elsevier Inc.
Similar articles
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Intrathymic injection of hematopoietic progenitor cells establishes functional T cell development in a mouse model of severe combined immunodeficiency.J Hematol Oncol. 2017 May 16;10(1):109. doi: 10.1186/s13045-017-0478-z. J Hematol Oncol. 2017. PMID: 28511686 Free PMC article.
-
New Insights on the Role of the Mesenchymal-Hematopoietic Stem Cell Axis in Autologous and Allogeneic Hematopoiesis.Stem Cells Dev. 2021 Jan 1;30(1):2-16. doi: 10.1089/scd.2020.0148. Epub 2020 Dec 16. Stem Cells Dev. 2021. PMID: 33231142 Review.
-
NOD Scid Gamma Mice Are Permissive to Allogeneic HSC Transplantation without Prior Conditioning.Int J Mol Sci. 2016 Nov 7;17(11):1850. doi: 10.3390/ijms17111850. Int J Mol Sci. 2016. PMID: 27827995 Free PMC article.
-
Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.Biol Blood Marrow Transplant. 1996 Feb;2(1):3-14. Biol Blood Marrow Transplant. 1996. PMID: 9078349
Cited by
-
Fine mapping of the Bmgr5 quantitative trait locus for allogeneic bone marrow engraftment in mice.Immunogenetics. 2013 Aug;65(8):585-96. doi: 10.1007/s00251-013-0709-6. Epub 2013 May 12. Immunogenetics. 2013. PMID: 23666360 Free PMC article.
-
Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice.Immunogenetics. 2013 Aug;65(8):597-607. doi: 10.1007/s00251-013-0710-0. Epub 2013 May 24. Immunogenetics. 2013. PMID: 23703256 Free PMC article.
-
The road to purified hematopoietic stem cell transplants is paved with antibodies.Curr Opin Immunol. 2012 Oct;24(5):640-8. doi: 10.1016/j.coi.2012.08.002. Epub 2012 Aug 29. Curr Opin Immunol. 2012. PMID: 22939368 Free PMC article. Review.
-
Effects of conditioning regimens and T cell depletion in hematopoietic cell transplantation for primary immune deficiency.Biol Blood Marrow Transplant. 2012 Dec;18(12):1911-20. doi: 10.1016/j.bbmt.2012.07.014. Epub 2012 Jul 27. Biol Blood Marrow Transplant. 2012. PMID: 22842333 Free PMC article.
-
Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients.Transplant Cell Ther. 2021 Oct;27(10):852.e1-852.e9. doi: 10.1016/j.jtct.2021.06.022. Epub 2021 Jun 30. Transplant Cell Ther. 2021. PMID: 34214736 Free PMC article. Clinical Trial.
References
-
- Shizuru JA, Negrin RS, Weissman IL. Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system. Annu Rev Med. 2005;56:509–538. - PubMed
-
- Dvorak CC, Cowan MJ. Hematopoietic stem cell transplantation for primary immunodeficiency disease. Bone Marrow Transplant. 2008;41:119–126. - PubMed
-
- Zimmerman Z, Jones M, Shatry A, Komatsu M, Mammolenti M, Levy R. Cytolytic pathways used by effector cells derived from recipient naive and memory T cells and natural killer cells in resistance to allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005;11:957–971. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources